WallStSmart
DD

Dupont De Nemours Inc

NYSE: DD · BASIC MATERIALS · SPECIALTY CHEMICALS

$44.62
-1.57% today

Updated 2026-04-29

Market cap
$18.29B
P/E ratio
212.48
P/S ratio
2.67x
EPS (TTM)
$0.21
Dividend yield
3.15%
52W range
$26 – $52
Volume
3.7M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Dupont De Nemours Inc (DD) Financial Forecast & Price Target 2030

Research-backed projections from analyst consensus, management guidance, and sector analysis.

Price target summary

Current
$44.62
Consensus
$62.07
+39.11%
2030 Target
$241.52
+441.28%
DCF
—
—
21 analysts:
11 Buy3 Hold0 Sell

Management guidance

No specific CEO revenue guidance found in available materials. Management completed $1.8B Aramids divestiture (April 2026), repositioning for higher-margin specialty chemicals focus in healthcare, water, construction, and industrial markets. Company issued full-year 2026 outlook but specific revenue targets not disclosed in research data.

Sources: Management guidance, analyst consensus, sector analysishigh confidence

Revenue & price projection

Actual revenue Projected revenue Base case Bull to bear range
Bull case (2030)
$405.57
$8.4B Rev × 20x P/S
Base case (2030)
$241.52
$8.4B Rev × 12x P/S
Bear case (2030)
$159.50
$8.4B Rev × 8x P/S

Financial forecast — research-backed

Metric2023202420252026 (E)2027 (E)2028 (E)2029 (E)2030 (E)
Revenue$12.1B$12.4B$6.8B$7.3B$7.6B$7.9B$8.2B$8.4B
Revenue growth—2.6%-44.7%6.9%3.9%3.7%3.5%3.5%
EPS$3.48$4.07$3.70$2.37$2.61$2.95$3.28$3.62
P/S ratio———12.0x12.0x12.0x12.0x12.0x
Implied price———$209.62$218.74$227.85$232.41$241.52

Catalysts & risks

Growth catalysts
+ Aramids divestiture completion (April 2026) improves margin profile and reduces earnings volatility
+ Focus on innovation-driven specialty materials in water treatment, healthcare, and industrial applications
+ Global chemical price cycle entering upward trajectory due to geopolitical tensions and supply constraints
+ Successful execution of reverse stock split to strengthen financial position
+ Minority equity stake (16%) in Arclin provides upside through high-return aramids business growth
Key risks
- Historical 5-year revenue CAGR of -13.7% reflects massive prior divestitures; normalized growth trajectory uncertain
- Negative profit margin (-11.4%) and negative EPS (TTM: -1.86) indicate ongoing operational challenges
- Weak construction market headwinds limit near-term growth in key end-markets
- Specialty chemicals sector faces cyclical commodity price volatility despite current upward price cycle
- Post-divestiture company is smaller and may have reduced scale advantages versus competitors like LyondellBasell

Methodology

Dupont De Nemours Inc's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 21 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.

WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 7, 2026.